Losartan

Quick links to important sections

Losartan

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Losartan

What is Losartan?

Here are the essential facts about Losartan's identity and classification.

Property Description
Active ingredient Losartan (International Nonproprietary Name)
Form Oral Tablet
Pharmacological class Angiotensin II Receptor Blocker (ARB)
Common use Management of High Blood Pressure
Origin Synthetic, Prescription-Only (Rx)

Losartan's Pharmacological Class and Composition

Losartan is a synthetic, prescription medication that belongs to the pharmacological class known as Angiotensin II Receptor Blockers (ARBs). It is the International Nonproprietary Name (INN) for the active ingredient, often used as its potassium salt form to ensure stability and bioavailability in oral tablets. This classification is important because it dictates the specific system Losartan targets to manage blood pressure. The drug is clinically recognized as the first-in-class compound of the ARB category to be developed and used in patients.

Therapeutic Purpose: What Losartan is Prescribed For

The general therapeutic purpose of Losartan is to provide long-term control of chronic hypertension and protect vital organs from high blood pressure damage. It is a foundational treatment and is typically administered as a once-daily tablet, which aids in patient adherence for chronic conditions. Losartan is prescribed to reduce blood pressure and to decrease the risk of serious cardiovascular events, such as stroke, especially in certain high-risk patients. Its use is intended to help mitigate life-threatening heart-related issues over time.

What side effects are possible with Losartan?

Possible Side Effects and Safety Information

Losartan's safety profile is formally defined in regulatory documents based on official classifications of adverse reactions, which are grouped by frequency and the affected System-Organ Class (SOC).


Adverse Reaction Scope

Classification Examples of Officially Documented Effects
Common (1 to 10 in 100 users) Dizziness, Upper Respiratory Tract Infection, Back Pain, Hypotension, Fatigue, Headache.
Uncommon / Rare Sleep disorders, Palpitation, Rash, Angioedema, Anaphylactic reaction, Hepatitis, Vasculitis.

Common effects are frequently reported and organized into SOC categories such as Nervous System Disorders (Dizziness) and Musculoskeletal Disorders (Back Pain). A persistent dry cough, while a known effect of the ARB class, is also documented in the safety profile.


Serious Adverse Reactions and Constraints

Serious adverse reactions specifically documented include Angioedema (swelling of the face, lips, throat, and tongue) and Anaphylactic reactions. The regulatory label also highlights the potential for Hyperkalemia (high serum potassium levels), especially with the concomitant use of potassium-sparing agents.

Population-Specific Safety Constraints are explicitly noted by government authorities. Losartan is strictly contraindicated during the second and third trimesters of pregnancy due to the risk of fetal injury or death. Specific cautions are also outlined for use in individuals with hepatic impairment, as increased systemic exposure to the drug is expected in this population. The risk of Hypotension may be more pronounced at the start of treatment for patients who are volume-depleted.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of Losartan is primarily characterized by clinical manifestations that result from an exaggerated hypotensive effect. The most likely presentation involves profound hypotension (dangerously low blood pressure), often accompanied by disturbances in heart rate, such as tachycardia (fast heartbeat). Bradycardia (slow heartbeat) may also occur secondary to vagal stimulation. Officially documented severe outcomes include the risk of acute renal failure and serious electrolyte imbalances like hyperkalemia (elevated serum potassium levels).

Regulatory guidance mandates that individuals seek emergency medical attention immediately in the event of suspected overdosage. Emergency services (911) must be called if the individual has collapsed, had a seizure, is experiencing trouble breathing, or cannot be awakened. The official label specifies that no specific antidote is known. Management is entirely symptomatic and supportive, focused on treating the clinical manifestations. Losartan and its active metabolite cannot be removed by hemodialysis due to high protein binding. Furthermore, neonates with a history of in-utero exposure require close observation for hypotension and hyperkalemia, which may necessitate specific medical procedures.

Therapeutic Uses of Losartan

What Losartan Treats: Main Uses and Benefits

Losartan is a prescription medication generally used to help with hypertension, or high blood pressure, which is a primary condition marked by increased physiological stress. Losartan supports the management of blood pressure and is commonly used in conditions characterized by periods of heightened symptoms.

Losartan is applied across therapeutic domains where additional symptomatic support is needed. It is considered relevant for easing the overall symptom burden associated with:

  1. High blood pressure,
  2. Kidney conditions in people with type 2 diabetes and hypertension, and
  3. Conditions where functional stability becomes affected, such as high blood pressure along with an enlarged heart muscle (left ventricular hypertrophy).

This treatment may be part of symptomatic management in scenarios where supportive relief is needed. In these clinical scenarios: “Losartan assists with maintaining functional stability in the context of these systemic conditions.” The appropriate use of Losartan contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Relief for Symptoms related to physical discomfort (Specifically, those associated with persistently high blood pressure.)

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Losartan is an angiotensin II receptor blocker (ARB) used to treat hypertension and certain heart and kidney conditions, but its use is restricted in several populations based on official regulatory documents.

Contraindications and Restrictions

Losartan must not be used (contraindicated) in the following groups:

  • Pregnant women during the second and third trimesters, as use is associated with serious risks to the developing fetus.
  • Patients with a known hypersensitivity or allergy to losartan or any component of the formulation.
  • Patients with severe hepatic impairment (severe liver disease).
  • Patients with diabetes mellitus or renal impairment (GFR less than 60 mL/min/1.73 m^2) who are also taking aliskiren-containing products.

Use is restricted, requires special consideration, or is not recommended in:

  • Pregnancy: Use during the first trimester is generally not recommended.
  • Pediatric patients: Use is not recommended in children under 6 years of age or in children with a low glomerular filtration rate.
  • Lactation/Breastfeeding: Use is not recommended due to unknown risks to the infant.
  • Hepatic impairment: A lower starting dose is recommended for patients with a history of mild-to-moderate liver impairment.
  • Volume- or salt-depleted patients: A lower initial dose is recommended for these patients.

Before initiating treatment, official labeling must be consulted for a complete review of all warnings and precautions.

What should I know about interactions with other medicines?

Losartan Interactions with other medicines and products

The interaction profile of Losartan, an Angiotensin II Receptor Blocker (ARB), is defined by regulatory documents based on the potential for altered exposure and additive pharmacodynamic effects with co-administered substances.

Documented Interaction Patterns

Interacting Substance/Class Official Interaction Description Restriction/Classification
Aliskiren Increased risk of hyperkalemia, hypotension, and renal function impairment. Contraindicated in patients with Type 2 Diabetes or Renal Impairment (GFR < 60 ml/min/1.73 m^2)
Lithium Losartan may reduce Lithium's renal clearance, leading to increased risk of toxicity. Requires monitoring and possible adjustment of Lithium dosage.
NSAIDs (incl. COX-2 inhibitors) May result in reduced antihypertensive effect and increased risk of renal function deterioration. Higher risk in elderly or volume-depleted patients.
Potassium-Sparing Agents (e.g., Spironolactone) Additive effect leading to increased risk of hyperkalemia (high potassium levels). Co-administration is generally not recommended.
Fluconazole (CYP2C9 inhibitor) Documented to increase the systemic exposure (AUC) of Losartan. Pharmacokinetic Interaction.
Rifampin (CYP inducer) Documented to reduce the systemic exposure (AUC) of Losartan and its active metabolite. Pharmacokinetic Interaction.

Official Constraints

The co-administration of Losartan is also formally contraindicated in patients with severe hepatic impairment due to the significantly increased plasma concentrations of the medication in this population. The combination of Losartan with other agents that inhibit the Renin-Angiotensin System (RAS), such as ACE-inhibitors, is generally not recommended due to dual blockade risks.

Mechanism of Action

Losartan is an orally active, non-peptide Angiotensin II Type 1 ( AT1) receptor antagonist. Its primary action is the selective blockade of the Renin-Angiotensin-Aldosterone System ( RAAS). Following administration, Losartan undergoes metabolism to its principal, more potent active metabolite, E-3174. Both Losartan and E-3174 act at the AT1 receptor, exhibiting competitive and selective binding

. This interaction prevents the endogenous ligand, Angiotensin II, from binding to and activating the AT1 receptor. The functional consequence of AT1 receptor activation prevention is the inhibition of several downstream cellular processes, including vasoconstriction and the release of aldosterone from the adrenal cortex. This cascade leads directly to the modulation of systemic vascular resistance and a resultant decrease in vascular tone.

Dosage and Administration Information

How Losartan is Used

Losartan is a medication administered through the oral route as a tablet, or as a specially prepared oral suspension for certain patient populations. The standard regimen involves taking the medication once daily (qDay) for continuous, long-term management of chronic conditions such as high blood pressure. The tablets may be administered with or without food and should be swallowed whole with water.


Official Dosing Principles and Adjustments

The treatment protocol begins with a standardized starting dose for most adults, but dose adjustments are implemented based on patient status. The maximal blood pressure-lowering effect is typically achieved after three to six weeks of therapy.

Patient Population/Condition Initial Dose (Once Daily) Maintenance/Maximum Dose
Most Adults (Standard) 50 mg Up to 100 mg
Volume-Depleted/Hepatic Impairment 25 mg Up to 100 mg
Pediatric Patients (≥ 6 years) 0.7 mg/kg (Max 50 mg) Up to 1.4 mg/kg (Max 100 mg)

In adults with mild-to-moderate hepatic impairment, a lower starting dose of 25 mg once daily is required. Similarly, a 25 mg starting dose is used for patients who are volume- or salt-depleted, which must be addressed prior to initiation. For pediatric patients aged 6 years and older, dosing is determined based on body weight. If a dose is missed, the protocol is to take the next scheduled dose at the usual time and to avoid doubling the dose to compensate.

Recent Clinical Evidence

Research evidence / Overview of Studies for Losartan

This section provides a factual outline of the clinical research conducted on Losartan, detailing the types of studies, the populations examined, and the specific health outcomes that were monitored. The information presented here reflects group-level patterns observed in research and does not offer individual medical advice or predictions.


Evidence for Losartan in Managing High Blood Pressure

Losartan was studied for use in adults with essential hypertension through large-scale Randomized Controlled Trials (RCTs) and systematic reviews referenced by regulators. Research in this area examined outcomes related to physiological strain or stress, such as blood pressure measurements (systolic and diastolic pressures). Long-term research examined data on major cardiovascular events, such as nonfatal stroke and cardiovascular death, as part of the study monitoring.

Trials reported measurable changes in blood pressure compared to baseline levels in the general hypertensive populations examined. In one large, long-term trial focused on high-risk patients (those with an enlarged heart muscle), findings indicate patterns related to the frequency of nonfatal stroke that differed in the Losartan group compared to the active comparator group.

Evidence in Patients with Type 2 Diabetes and Kidney Disease

Dedicated, multi-year Randomized Controlled Trials (RCTs) was evaluated in patients with high blood pressure who also had Type 2 Diabetes and confirmed evidence of kidney disease (diabetic nephropathy). This research examined renal outcomes related to systemic or functional imbalance in the kidneys. The primary endpoints monitored were the progression to end-stage renal disease (ESRD), which is defined by the need for dialysis or transplant, and significant changes in key markers like serum creatinine and proteinuria.

What Research Gaps and Uncertainty Remain

Synthesis of the available evidence reveals several areas where certainty remains low. As noted, results apply only to the populations studied, focusing mainly on high-risk adults with hypertension, LVH, or diabetic kidney disease. Comparative evidence is lacking for a full range of head-to-head studies against all other common drug classes. Furthermore, though some long-term data exists, there is limited information for long-term outcomes that extend far beyond the typical follow-up periods of four to five years in the major trials.

Key Studies & References

  1. Losartan: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Losartan (FAQ)


Q: How long does it usually take for Losartan to start working on blood pressure?

A: While the medication begins working immediately, the maximal blood pressure-lowering effect is typically observed after a period of three to six weeks of continuous, daily therapy. Official documents indicate that this duration of use is generally needed to assess the full therapeutic benefit.

Q: What evidence exists about Losartan's use in younger people?

A: Official information indicates that Losartan is approved for the treatment of high blood pressure, also known as hypertension, in pediatric patients who are six years of age and older. Dosing principles for this age group are based on body weight, as outlined in official prescribing information.

Q: Why is Losartan not recommended for people who are pregnant?

A: Losartan, like other drugs that act on the Renin-Angiotensin System, is associated with significant safety concerns during pregnancy. Specifically, a boxed warning in US labeling states that using this medication during the second and third trimesters can cause injury and death to the developing fetus.

Q: What are the signs that Losartan is not working for me?

A: Regulatory information indicates that the full therapeutic effect of Losartan may take three to six weeks to be achieved. If an appropriate reduction in blood pressure is not observed after this period, further assessment by a healthcare professional is generally required to determine the next steps in treatment.

Q: Is Losartan the same as a water pill?

A: No. Losartan is classified as an Angiotensin II Receptor Blocker (ARB), which works by blocking specific hormone receptors involved in blood pressure control. A water pill, or diuretic, works differently by increasing the output of salt and water. However, Losartan is often used in combination with a diuretic for a broader approach to high blood pressure management.

Q: Can Losartan cause my ankles or feet to swell?

A: Swelling due to fluid retention, known as edema, has been reported as an uncommon side effect in some postmarketing surveillance data. Swelling that occurs should be reviewed by a healthcare professional.

Q: Is it true that Losartan can affect my kidneys?

A: Official indications show Losartan is used to reduce the risk of renal disease progression in people with Type 2 diabetes and high blood pressure. Conversely, warnings also state that it can cause changes in kidney function (including failure) in certain individuals, making regular monitoring of kidney health important.

Q: Can Losartan make me feel dizzy or lightheaded when I stand up?

A: Dizziness is listed as a commonly reported adverse reaction in official product information. This effect, which may be related to lower blood pressure, can occur, particularly when a person moves quickly from a sitting or lying position to standing.

Q: What is the difference between Losartan and Lisinopril?

A: Losartan and Lisinopril belong to two different classes of medication. Losartan is an Angiotensin II Receptor Blockers (ARB), while Lisinopril is an Angiotensin-Converting Enzyme (ACE) inhibitor. While both classes target the same body system to control blood pressure, they achieve this through distinct mechanisms.

Q: Does Losartan help with anything other than high blood pressure?

A: Yes, official indications show Losartan is also prescribed for other purposes. It is indicated for the treatment of kidney disease (diabetic nephropathy) in patients with Type 2 diabetes, and for the reduction of stroke risk in certain patients with high blood pressure and an enlarged heart (left ventricular hypertrophy).

Q: Is Losartan a beta-blocker?

A: No. Losartan is an Angiotensin II Receptor Blocker (ARB). Beta-blockers are a completely different class of medication that act on different receptors to affect heart rate and blood pressure.

Q: Are there any foods or drinks I should avoid while taking Losartan?

A: Official documents advise against the co-administration of potassium supplements and salt substitutes that contain potassium. Losartan can increase potassium levels in the blood, and taking these products concurrently increases the risk of high potassium (hyperkalemia).

Q: Can I take ibuprofen or other pain relievers while on Losartan?

A: Regulatory documents warn that Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which include ibuprofen or naproxen, may reduce the blood pressure-lowering effect of Losartan. Regulatory documents state that co-administration of these medications may increase the risk of kidney function deterioration, particularly in certain individuals.

Q: Can older adults use Losartan safely?

A: Official information indicates that the way the body processes the medication (pharmacokinetics) is similar in elderly and younger patients with high blood pressure. Therefore, dosing adjustment is not typically needed solely based on age.

Q: Is Losartan known to cause a cough like some other blood pressure medicines?

A: Cough is listed as an adverse reaction in postmarketing experience data. While cough may be less common with Losartan than with a different class of blood pressure medicines (ACE inhibitors), it is documented as a possible side effect. Persistent cough is an event that should be reviewed by a healthcare provider.

Q: Can Losartan cause problems with my sleep?

A: Insomnia, or difficulty sleeping, is listed in official documentation as an infrequent or uncommon adverse reaction. Changes to sleep patterns, if noted, are typically reviewed by a healthcare provider.

Q: If Losartan lowers my blood pressure too much, what should I look for?

A: Official warnings mention that symptoms of excessively low blood pressure (hypotension) may occur. These symptoms can include feeling very dizzy or lightheaded. These symptoms are listed in official warnings as potential indicators of low blood pressure.

Q: Is Losartan considered a long-term medication?

A: Yes. Losartan is indicated for the treatment of chronic conditions such as high blood pressure and is typically used for continuous, long-term management to control these conditions.

Q: Does Losartan interact with herbal supplements like ginseng or St. John's Wort?

A: Official documentation advises that patients inform their healthcare provider about all medicines and supplements being taken, including herbal supplements. Additionally, it strongly advises against using potassium-containing supplements or salt substitutes.

Q: Why are people with diabetes sometimes prescribed Losartan?

A: Losartan is officially indicated to reduce the rate of progression of kidney disease (diabetic nephropathy) in patients who have high blood pressure and Type 2 diabetes. This use is based on evidence specific to this patient group.

Q: Can Losartan affect a person's ability to drive?

A: Official documents advise caution when driving or operating machinery. This warning is due to potential side effects like dizziness or vertigo. Official documents advise that caution should be exercised when driving or operating machinery until an individual is aware of how the medication affects them.

Q: Is there a generic version of Losartan available?

A: Yes. Losartan is the generic name for the medication originally sold under the brand name Cozaar. The FDA requires that generic products must be equivalent to the brand-name drug in safety, strength, quality, and effectiveness.

Q: Are headaches a common side effect of Losartan?

A: Headache is listed in the official adverse reaction data as a frequently reported side effect. Side effects should always be discussed with a healthcare provider.

Q: Is Losartan used to prevent strokes or heart attacks?

A: Losartan is officially indicated for the reduction of the risk of stroke in patients who have high blood pressure and left ventricular hypertrophy (enlargement of the heart's pumping chamber).

Q: Can Losartan cause muscle cramps or joint pain?

A: Muscle cramps, muscle pain (myalgia), and joint pain (arthralgia) are listed in official documents as infrequent or uncommon adverse reactions. These potential effects are monitored during postmarketing surveillance.

Q: Is it safe to take cold and flu medicines with Losartan?

A: Official documents caution against concurrent use of NSAIDs, which are common ingredients in some cold and flu medications, due to potential risks to kidney function. It is always advised to consult a healthcare provider before self-treating cold or flu symptoms.

Q: Are there different strengths or dosages of Losartan?

A: Yes. Losartan potassium is officially available in multiple tablet strengths. The most common strengths listed in official prescribing information are 25 mg, 50 mg, and 100 mg.

Q: Does Losartan interact with alcohol?

A: Official sources describe that the co-consumption of alcohol with Losartan may cause an additive effect in lowering blood pressure. This may increase the risk of side effects such as dizziness or lightheadedness.

Q: Will Losartan cure my high blood pressure?

A: Losartan is described in regulatory patient information as a treatment intended to control high blood pressure, but it does not cure it. High blood pressure typically requires long-term management.

Q: Are there any specific laboratory tests required when taking Losartan?

A: Official documents recommend that patients have their serum potassium levels monitored periodically. Close monitoring of kidney function (such as serum creatinine) is also advised, especially in patients with existing kidney issues or those taking certain interacting medicines.

Q: Can Losartan change the way other medications work?

A: Yes. Losartan is known to interact with certain other medicines, which can lead to changes in the level of Losartan or the other medication in the body, or cause an additive effect. Official warnings detail these potential interactions.

Q: Does Losartan affect blood sugar levels?

A: In clinical trials for diabetic kidney disease, low blood sugar (hypoglycemia) was reported as a common adverse reaction in patients who were also receiving treatment for diabetes.

Q: Why do official documents warn about taking salt substitutes with Losartan?

A: Official documents warn against salt substitutes because they often contain potassium chloride. Since Losartan can cause an increase in potassium levels in the blood, the concurrent use of potassium-containing salt substitutes increases the risk of high potassium (hyperkalemia).

Q: Is there any research on Losartan helping with kidney disease?

A: Yes. Losartan is officially indicated for the reduction of the rate of progression of kidney disease (diabetic nephropathy) in specific patients, particularly those with high blood pressure and Type 2 diabetes.

Q: Can Losartan affect sexual function?

A: Erectile dysfunction has been reported in postmarketing data as a possible adverse reaction. This is an effect that should be reported to a healthcare provider if it occurs.

Q: Is the brand name version of Losartan different from the generic?

A: The FDA mandates that a generic drug, such as Losartan, must be equivalent to its brand-name counterpart (Cozaar) in terms of safety, strength, quality, and effectiveness. There is no required difference in how they work.

Q: Does Losartan lose its effectiveness over time?

A: The official documents describing how the body processes the drug (pharmacokinetics) indicate that these processes are linear and do not change over time upon repeated once-daily dosing. The medication is intended for long-term use.

Q: Can Losartan cause stomach upset or nausea?

A: Nausea, diarrhea, and abdominal pain are all listed in the official adverse reaction data. These are potential side effects that may occur with the use of the medication.

Q: What should I do if I get a rash after starting Losartan?

A: Official documentation lists rash as an adverse reaction and warns about potential hypersensitivity reactions. These potential reactions, which include swelling of the face or throat (angioedema), are listed in official documents as severe events that warrant immediate medical review.

Q: Are there any known severe allergic reactions to Losartan?

A: Yes. Official documents contain warnings regarding the potential for severe hypersensitivity reactions. These can include angioedema (swelling of the face, lips, tongue, and/or throat) and anaphylaxis, which are serious events that warrant immediate medical review.

Q: Does Losartan help protect the heart?

A: Yes. Losartan is officially indicated for the reduction of the risk of stroke in patients with high blood pressure and left ventricular hypertrophy, which is a condition involving the structure of the heart.

Q: Is it important to take Losartan at the exact same time every day?

A: Losartan is typically prescribed for once-daily administration. Taking the medication around the same time each day is generally considered a way to support consistent blood levels and maintain the intended therapeutic effect.

How should Losartan be stored and disposed of?

How to Store and Dispose of Losartan?

The official instructions for Losartan Potassium tablets are designed to maintain product stability and ensure public safety.


Official Storage Requirements

Losartan must be stored at controlled room temperature, typically between 20 C to 25 C (68 F to 77 F). To prevent degradation, the tablets must be protected from moisture and excessive heat and kept in the original container, tightly closed. Storage environments with high humidity, such as bathrooms, should be avoided.

Child Safety and Disposal

It is a mandatory regulatory requirement to keep Losartan out of the sight and reach of children.

For disposal, unused or expired medication must not be flushed down the toilet or poured down a drain. Patients should consult a pharmacist or local collection program for guidance on the proper disposal of pharmaceuticals to ensure environmental compliance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Losartan found in:

A-Z Index: